Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$56.67 - $69.36 $11,957 - $14,634
211 Added 20.67%
1,232 $84,000
Q4 2023

Feb 02, 2024

BUY
$49.38 - $63.75 $1,185 - $1,530
24 Added 2.41%
1,021 $63,000
Q3 2023

Nov 01, 2023

BUY
$48.64 - $62.51 $48,494 - $62,322
997 New
997 $55,000
Q1 2023

Apr 27, 2023

BUY
$52.6 - $67.34 $59,595 - $76,296
1,133 New
1,133 $61,000
Q2 2022

Aug 03, 2022

BUY
$39.5 - $64.42 $26,425 - $43,096
669 Added 39.54%
2,361 $133,000
Q1 2022

May 02, 2022

BUY
$43.74 - $62.76 $74,008 - $106,189
1,692 New
1,692 $105,000
Q1 2021

Apr 26, 2021

SELL
$49.14 - $59.89 $572,382 - $697,598
-11,648 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$42.19 - $51.5 $45,944 - $56,083
1,089 Added 10.31%
11,648 $581,000
Q3 2020

Oct 14, 2020

BUY
$35.33 - $51.04 $219,469 - $317,060
6,212 Added 142.9%
10,559 $538,000
Q2 2020

Jul 13, 2020

BUY
$22.91 - $39.83 $89,509 - $155,615
3,907 Added 887.95%
4,347 $152,000
Q1 2020

Apr 29, 2020

BUY
$16.44 - $37.73 $7,233 - $16,601
440 New
440 $11,000
Q4 2019

Feb 05, 2020

SELL
$19.57 - $28.96 $4,579 - $6,776
-234 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$26.92 - $42.41 $6,299 - $9,923
234 New
234 $6,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.